
Oncology
Large Cohort Study Links GLP-1 Use to Lower Breast Cancer Incidence
A retrospective study of 111,646 women found those taking GLP-1 medications had roughly 30 percent lower odds of developing breast cancer, though the authors stress the link is not yet proven.
Read Analysis arrow_forward









